10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

RTA Laboratuvarlari Biyolojik
Buy, Hold or Sell?

Let's analyze RTA Laboratuvarlari Biyolojik together

I guess you are interested in RTA Laboratuvarlari Biyolojik. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of RTA Laboratuvarlari Biyolojik. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about RTA Laboratuvarlari Biyolojik

I send you an email if I find something interesting about RTA Laboratuvarlari Biyolojik.

1. Quick Overview

1.1. Quick analysis of RTA Laboratuvarlari Biyolojik (30 sec.)










1.2. What can you expect buying and holding a share of RTA Laboratuvarlari Biyolojik? (30 sec.)

How much money do you get?

How much money do you get?
₺0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₺6.33
Expected worth in 1 year
₺17.91
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
₺11.58
Return On Investment
68.0%

For what price can you sell your share?

Current Price per Share
₺17.04
Expected price per share
₺13.57 - ₺32.56
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of RTA Laboratuvarlari Biyolojik (5 min.)




Live pricePrice per Share (EOD)
₺17.04
Intrinsic Value Per Share
₺-14.03 - ₺-5.05
Total Value Per Share
₺-7.70 - ₺1.28

2.2. Growth of RTA Laboratuvarlari Biyolojik (5 min.)




Is RTA Laboratuvarlari Biyolojik growing?

Current yearPrevious yearGrowGrow %
How rich?$18.4m$9.9m$8.4m45.8%

How much money is RTA Laboratuvarlari Biyolojik making?

Current yearPrevious yearGrowGrow %
Making money$8.1m$3.3m$4.8m59.3%
Net Profit Margin326.8%29.8%--

How much money comes from the company's main activities?

2.3. Financial Health of RTA Laboratuvarlari Biyolojik (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#562 / 959

Most Revenue
#425 / 959

Most Profit
#78 / 959
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of RTA Laboratuvarlari Biyolojik?

Welcome investor! RTA Laboratuvarlari Biyolojik's management wants to use your money to grow the business. In return you get a share of RTA Laboratuvarlari Biyolojik.

First you should know what it really means to hold a share of RTA Laboratuvarlari Biyolojik. And how you can make/lose money.

Speculation

The Price per Share of RTA Laboratuvarlari Biyolojik is ₺17.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of RTA Laboratuvarlari Biyolojik.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in RTA Laboratuvarlari Biyolojik, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₺6.33. Based on the TTM, the Book Value Change Per Share is ₺2.90 per quarter. Based on the YOY, the Book Value Change Per Share is ₺1.75 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₺0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of RTA Laboratuvarlari Biyolojik.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.080.5%0.080.5%0.030.2%0.030.2%0.010.1%
Usd Book Value Change Per Share0.080.5%0.080.5%0.050.3%0.030.2%0.020.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.080.5%0.080.5%0.050.3%0.030.2%0.020.1%
Usd Price Per Share0.38-0.38-0.64-0.40-0.30-
Price to Earnings Ratio4.62-4.62-19.34-41.05-83.46-
Price-to-Total Gains Ratio4.49-4.49-12.62-24.83-67.52-
Price to Book Ratio2.05-2.05-6.45-6.45-10.36-
Price-to-Total Gains Ratio4.49-4.49-12.62-24.83-67.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.495864
Number of shares2016
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.080.03
Usd Total Gains Per Share0.080.03
Gains per Quarter (2016 shares)169.8467.87
Gains per Year (2016 shares)679.36271.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
106796690271261
20135913480543532
30203820270814803
4027172706010861074
5033973385013571345
6040764064016291616
7047564743019001887
8054355422021722158
9061146101024432429
10067946780027152700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%9.00.04.069.2%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.01.00.092.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%3.00.010.023.1%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of RTA Laboratuvarlari Biyolojik compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.8952.8950%1.754+65%1.157+150%0.622+366%
Book Value Per Share--6.3276.3270%3.432+84%2.575+146%1.497+323%
Current Ratio--3.3933.3930%1.803+88%3.263+4%3.295+3%
Debt To Asset Ratio--0.1450.1450%0.379-62%0.225-35%0.220-34%
Debt To Equity Ratio--0.1810.1810%0.669-73%0.346-48%0.315-43%
Dividend Per Share----0%-0%-0%-0%
Eps--2.8112.8110%1.145+146%0.926+203%0.483+482%
Free Cash Flow Per Share---1.535-1.5350%0.470-427%-0.248-84%-0.114-93%
Free Cash Flow To Equity Per Share---1.505-1.5050%1.229-222%-0.005-100%0.022-6992%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max---5.046--------
Intrinsic Value_10Y_min---14.031--------
Intrinsic Value_1Y_max---0.199--------
Intrinsic Value_1Y_min---0.645--------
Intrinsic Value_3Y_max---0.832--------
Intrinsic Value_3Y_min---2.609--------
Intrinsic Value_5Y_max---1.746--------
Intrinsic Value_5Y_min---5.292--------
Market Cap1704000000.000+24%1299000000.0001299000000.0000%2214000000.000-41%1389400000.000-7%1014202000.000+28%
Net Profit Margin--3.2683.2680%0.298+997%0.825+296%0.475+587%
Operating Margin---0.091-0.0910%0.247-137%-0.053-41%0.036-351%
Operating Ratio--1.6861.6860%1.341+26%1.673+1%1.468+15%
Pb Ratio2.693+24%2.0532.0530%6.450-68%6.455-68%10.363-80%
Pe Ratio6.062+24%4.6214.6210%19.341-76%41.045-89%83.459-94%
Price Per Share17.040+24%12.99012.9900%22.140-41%13.894-7%10.142+28%
Price To Free Cash Flow Ratio-11.097-31%-8.460-8.4600%47.129-118%-108.737+1185%230.515-104%
Price To Total Gains Ratio5.886+24%4.4874.4870%12.621-64%24.830-82%67.519-93%
Quick Ratio--2.2602.2600%0.535+323%1.718+32%1.439+57%
Return On Assets--0.3800.3800%0.207+83%0.176+116%0.123+210%
Return On Equity--0.4730.4730%0.366+29%0.261+81%0.175+170%
Total Gains Per Share--2.8952.8950%1.754+65%1.157+150%0.622+366%
Usd Book Value--18412727.19118412727.1910%9988117.490+84%7493464.962+146%4356856.295+323%
Usd Book Value Change Per Share--0.0840.0840%0.051+65%0.034+150%0.018+366%
Usd Book Value Per Share--0.1840.1840%0.100+84%0.075+146%0.044+323%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0820.0820%0.033+146%0.027+203%0.014+482%
Usd Free Cash Flow---4468281.516-4468281.5160%1367042.369-427%-720792.485-84%-332254.313-93%
Usd Free Cash Flow Per Share---0.045-0.0450%0.014-427%-0.007-84%-0.003-93%
Usd Free Cash Flow To Equity Per Share---0.044-0.0440%0.036-222%0.000-100%0.001-6992%
Usd Market Cap49586400.000+24%37800900.00037800900.0000%64427400.000-41%40431540.000-7%29513278.200+28%
Usd Price Per Share0.496+24%0.3780.3780%0.644-41%0.404-7%0.295+28%
Usd Profit--8180504.8758180504.8750%3331183.739+146%2686209.209+205%1402078.478+483%
Usd Revenue--2503356.2512503356.2510%11184341.753-78%4295441.688-42%2581431.658-3%
Usd Total Gains Per Share--0.0840.0840%0.051+65%0.034+150%0.018+366%
 EOD+5 -3MRQTTM+0 -0YOY+21 -125Y+20 -1310Y+24 -10

3.3 Fundamental Score

Let's check the fundamental score of RTA Laboratuvarlari Biyolojik based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.062
Price to Book Ratio (EOD)Between0-12.693
Net Profit Margin (MRQ)Greater than03.268
Operating Margin (MRQ)Greater than0-0.091
Quick Ratio (MRQ)Greater than12.260
Current Ratio (MRQ)Greater than13.393
Debt to Asset Ratio (MRQ)Less than10.145
Debt to Equity Ratio (MRQ)Less than10.181
Return on Equity (MRQ)Greater than0.150.473
Return on Assets (MRQ)Greater than0.050.380
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of RTA Laboratuvarlari Biyolojik based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.952
Ma 20Greater thanMa 5017.601
Ma 50Greater thanMa 10018.691
Ma 100Greater thanMa 20015.806
OpenGreater thanClose17.360
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About RTA Laboratuvarlari Biyolojik

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, and swab products; and molecular biology products, such as nucleic acid isolation kits, real time PCR kits, and voltran viral load detection systems. The company was incorporated in 1996 and is based in Kocaeli, Turkey.

Fundamental data was last updated by Penke on 2024-11-06 19:37:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit RTA Laboratuvarlari Biyolojik earns for each ₤1 of revenue.

  • Above 10% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Net Profit Margin of 326.8% means that ₤3.27 for each ₤1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 326.8%. The company is making a huge profit. +2
  • The TTM is 326.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ326.8%TTM326.8%0.0%
TTM326.8%YOY29.8%+297.0%
TTM326.8%5Y82.5%+244.3%
5Y82.5%10Y47.5%+34.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ326.8%-135.3%+462.1%
TTM326.8%-204.4%+531.2%
YOY29.8%-207.5%+237.3%
5Y82.5%-353.2%+435.7%
10Y47.5%-464.5%+512.0%
4.3.1.2. Return on Assets

Shows how efficient RTA Laboratuvarlari Biyolojik is using its assets to generate profit.

  • Above 5% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • 38.0% Return on Assets means that RTA Laboratuvarlari Biyolojik generated ₤0.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 38.0%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 38.0%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ38.0%TTM38.0%0.0%
TTM38.0%YOY20.7%+17.3%
TTM38.0%5Y17.6%+20.4%
5Y17.6%10Y12.3%+5.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ38.0%-10.7%+48.7%
TTM38.0%-11.8%+49.8%
YOY20.7%-11.0%+31.7%
5Y17.6%-12.6%+30.2%
10Y12.3%-14.3%+26.6%
4.3.1.3. Return on Equity

Shows how efficient RTA Laboratuvarlari Biyolojik is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • 47.3% Return on Equity means RTA Laboratuvarlari Biyolojik generated ₤0.47 for each ₤1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 47.3%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 47.3%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ47.3%TTM47.3%0.0%
TTM47.3%YOY36.6%+10.7%
TTM47.3%5Y26.1%+21.2%
5Y26.1%10Y17.5%+8.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ47.3%-13.5%+60.8%
TTM47.3%-15.9%+63.2%
YOY36.6%-13.5%+50.1%
5Y26.1%-18.5%+44.6%
10Y17.5%-19.0%+36.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of RTA Laboratuvarlari Biyolojik.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient RTA Laboratuvarlari Biyolojik is operating .

  • Measures how much profit RTA Laboratuvarlari Biyolojik makes for each ₤1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • An Operating Margin of -9.1% means the company generated ₤-0.09  for each ₤1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is -9.1%. The company is operating very inefficient. -2
  • The TTM is -9.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-9.1%TTM-9.1%0.0%
TTM-9.1%YOY24.7%-33.7%
TTM-9.1%5Y-5.3%-3.7%
5Y-5.3%10Y3.6%-8.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.1%-277.1%+268.0%
TTM-9.1%-312.4%+303.3%
YOY24.7%-223.5%+248.2%
5Y-5.3%-384.9%+379.6%
10Y3.6%-494.6%+498.2%
4.3.2.2. Operating Ratio

Measures how efficient RTA Laboratuvarlari Biyolojik is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.69 means that the operating costs are ₤1.69 for each ₤1 in net sales.

Let's take a look of the Operating Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 1.686. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.686. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.686TTM1.6860.000
TTM1.686YOY1.341+0.345
TTM1.6865Y1.673+0.013
5Y1.67310Y1.468+0.205
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6862.842-1.156
TTM1.6863.179-1.493
YOY1.3413.301-1.960
5Y1.6734.794-3.121
10Y1.4686.520-5.052
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of RTA Laboratuvarlari Biyolojik.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.39 means the company has ₤3.39 in assets for each ₤1 in short-term debts.

Let's take a look of the Current Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 3.393. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.393. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.393TTM3.3930.000
TTM3.393YOY1.803+1.590
TTM3.3935Y3.263+0.130
5Y3.26310Y3.295-0.032
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3933.783-0.390
TTM3.3933.923-0.530
YOY1.8034.715-2.912
5Y3.2635.960-2.697
10Y3.2956.285-2.990
4.4.3.2. Quick Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Quick Ratio of 2.26 means the company can pay off ₤2.26 for each ₤1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 2.260. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.260. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.260TTM2.2600.000
TTM2.260YOY0.535+1.726
TTM2.2605Y1.718+0.542
5Y1.71810Y1.439+0.280
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2603.349-1.089
TTM2.2603.522-1.262
YOY0.5354.691-4.156
5Y1.7185.927-4.209
10Y1.4396.469-5.030
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of RTA Laboratuvarlari Biyolojik.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of RTA Laboratuvarlari Biyolojik assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare RTA Laboratuvarlari Biyolojik to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15 means that RTA Laboratuvarlari Biyolojik assets are financed with 14.5% credit (debt) and the remaining percentage (100% - 14.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.145. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.145. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.1450.000
TTM0.145YOY0.379-0.233
TTM0.1455Y0.225-0.079
5Y0.22510Y0.220+0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.338-0.193
TTM0.1450.347-0.202
YOY0.3790.309+0.070
5Y0.2250.365-0.140
10Y0.2200.380-0.160
4.5.4.2. Debt to Equity Ratio

Measures if RTA Laboratuvarlari Biyolojik is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A Debt to Equity ratio of 18.1% means that company has ₤0.18 debt for each ₤1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The MRQ is 0.181. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.181. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.181TTM0.1810.000
TTM0.181YOY0.669-0.488
TTM0.1815Y0.346-0.165
5Y0.34610Y0.315+0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1810.389-0.208
TTM0.1810.437-0.256
YOY0.6690.375+0.294
5Y0.3460.450-0.104
10Y0.3150.488-0.173
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₤1 in earnings RTA Laboratuvarlari Biyolojik generates.

  • Above 15 is considered overpriced but always compare RTA Laboratuvarlari Biyolojik to the Biotechnology industry mean.
  • A PE ratio of 4.62 means the investor is paying ₤4.62 for every ₤1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is 6.062. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.621. Based on the earnings, the company is cheap. +2
  • The TTM is 4.621. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.062MRQ4.621+1.441
MRQ4.621TTM4.6210.000
TTM4.621YOY19.341-14.720
TTM4.6215Y41.045-36.424
5Y41.04510Y83.459-42.414
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.062-2.431+8.493
MRQ4.621-2.454+7.075
TTM4.621-2.994+7.615
YOY19.341-3.435+22.776
5Y41.045-6.005+47.050
10Y83.459-6.275+89.734
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is -11.097. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.460. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.460. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.097MRQ-8.460-2.638
MRQ-8.460TTM-8.4600.000
TTM-8.460YOY47.129-55.589
TTM-8.4605Y-108.737+100.277
5Y-108.73710Y230.515-339.251
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.097-3.231-7.866
MRQ-8.460-3.234-5.226
TTM-8.460-3.528-4.932
YOY47.129-4.567+51.696
5Y-108.737-8.099-100.638
10Y230.515-8.945+239.460
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of RTA Laboratuvarlari Biyolojik is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.05 means the investor is paying ₤2.05 for each ₤1 in book value.

Let's take a look of the Price to Book Ratio trends of RTA Laboratuvarlari Biyolojik:

  • The EOD is 2.693. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.053. Based on the equity, the company is underpriced. +1
  • The TTM is 2.053. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.693MRQ2.053+0.640
MRQ2.053TTM2.0530.000
TTM2.053YOY6.450-4.397
TTM2.0535Y6.455-4.402
5Y6.45510Y10.363-3.908
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6931.938+0.755
MRQ2.0531.983+0.070
TTM2.0532.193-0.140
YOY6.4502.392+4.058
5Y6.4553.608+2.847
10Y10.3634.220+6.143
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in TRY. All numbers in thousands.

Summary
Total Assets740,213
Total Liabilities107,473
Total Stockholder Equity594,521
 As reported
Total Liabilities 107,473
Total Stockholder Equity+ 594,521
Total Assets = 740,213

Assets

Total Assets740,213
Total Current Assets300,531
Long-term Assets439,682
Total Current Assets
Cash And Cash Equivalents 31,363
Short-term Investments 118,082
Net Receivables 82,133
Inventory 27,249
Other Current Assets 30,309
Total Current Assets  (as reported)300,531
Total Current Assets  (calculated)289,135
+/- 11,396
Long-term Assets
Property Plant Equipment 53,680
Intangible Assets 449
Other Assets 11,663
Long-term Assets  (as reported)439,682
Long-term Assets  (calculated)65,792
+/- 373,890

Liabilities & Shareholders' Equity

Total Current Liabilities88,585
Long-term Liabilities18,888
Total Stockholder Equity594,521
Total Current Liabilities
Short Long Term Debt 67,076
Accounts payable 11,149
Other Current Liabilities 8,796
Total Current Liabilities  (as reported)88,585
Total Current Liabilities  (calculated)87,021
+/- 1,564
Long-term Liabilities
Long term Debt 1,577
Capital Lease Obligations Min Short Term Debt1,183
Other Liabilities 16,489
Long-term Liabilities  (as reported)18,888
Long-term Liabilities  (calculated)19,249
+/- 361
Total Stockholder Equity
Common Stock100,000
Retained Earnings 463,841
Other Stockholders Equity 8,865
Total Stockholder Equity (as reported)594,521
Total Stockholder Equity (calculated)572,706
+/- 21,815
Other
Capital Stock100,000
Common Stock Shares Outstanding 100,000
Net Debt 37,290
Net Invested Capital 663,174
Net Tangible Assets 594,072
Net Working Capital 212,336
Property Plant and Equipment Gross 71,209



6.2. Balance Sheets Structured

Currency in TRY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
16,857
16,604
20,450
29,352
49,042
61,614
60,893
63,092
66,052
98,160
256,525
552,404
740,213
740,213552,404256,52598,16066,05263,09260,89361,61449,04229,35220,45016,60416,857
   > Total Current Assets 
0
0
0
0
36,222
38,662
37,436
40,847
32,864
34,561
142,975
369,387
300,531
300,531369,387142,97534,56132,86440,84737,43638,66236,2220000
       Cash And Cash Equivalents 
5,472
2,913
2,745
3,246
18,570
15,736
13,790
15,124
6,141
12,379
15,662
157,539
31,363
31,363157,53915,66212,3796,14115,12413,79015,73618,5703,2462,7452,9135,472
       Short-term Investments 
0
0
0
0
0
0
1,735
1,697
51
0
917
5,863
118,082
118,0825,8639170511,6971,735000000
       Net Receivables 
4,575
4,649
7,204
5,501
7,847
9,364
9,872
14,865
18,515
16,310
73,833
103,661
82,133
82,133103,66173,83316,31018,51514,8659,8729,3647,8475,5017,2044,6494,575
       Other Current Assets 
512
628
863
808
1,419
2,742
2,053
1,390
3,984
2,763
21,661
41,830
30,309
30,30941,83021,6612,7633,9841,3902,0532,7421,419808863628512
   > Long-term Assets 
0
0
0
0
0
0
23,457
22,244
33,188
63,600
113,550
183,017
439,682
439,682183,017113,55063,60033,18822,24423,457000000
       Property Plant Equipment 
2,191
1,836
3,237
8,061
8,246
10,062
11,616
9,482
11,167
14,781
31,399
46,754
53,680
53,68046,75431,39914,78111,1679,48211,61610,0628,2468,0613,2371,8362,191
       Goodwill 
0
0
0
0
0
1,031
1,031
1,031
1,031
0
0
0
0
00001,0311,0311,0311,03100000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
28,193
0
0
0
00028,193000000000
       Intangible Assets 
357
1,047
1,127
808
680
158
53
1,011
687
477
760
564
449
4495647604776871,011531586808081,1271,047357
       Long-term Assets Other 
0
0
0
0
0
0
23,457
22,244
33,188
63,600
0
0
0
00063,60033,18822,24423,457000000
> Total Liabilities 
5,393
6,412
9,459
8,519
11,399
14,878
10,690
8,841
8,990
11,466
88,719
209,170
107,473
107,473209,17088,71911,4668,9908,84110,69014,87811,3998,5199,4596,4125,393
   > Total Current Liabilities 
4,987
6,062
8,963
7,043
9,725
9,831
9,278
8,264
6,625
7,808
82,514
204,880
88,585
88,585204,88082,5147,8086,6258,2649,2789,8319,7257,0438,9636,0624,987
       Short-term Debt 
0
0
0
0
254
3,470
1,321
1,595
637
6,109
0
0
0
0006,1096371,5951,3213,4702540000
       Short Long Term Debt 
0
0
0
0
254
3,470
1,321
1,595
637
6,109
21,910
55,121
67,076
67,07655,12121,9106,1096371,5951,3213,4702540000
       Accounts payable 
2,254
3,894
5,234
5,530
7,573
7,224
5,902
4,862
5,260
1,438
23,557
101,272
11,149
11,149101,27223,5571,4385,2604,8625,9027,2247,5735,5305,2343,8942,254
       Other Current Liabilities 
1,791
1,176
2,412
1,505
1,898
2,181
1,519
1,667
113
83
29,922
45,750
8,796
8,79645,75029,922831131,6671,5192,1811,8981,5052,4121,1761,791
   > Long-term Liabilities 
0
0
0
0
0
0
1,412
578
330
3,657
6,204
4,289
18,888
18,8884,2896,2043,6573305781,412000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-254
-3,470
-1,319
-1,595
-637
-6,109
985
528
1,183
1,183528985-6,109-637-1,595-1,319-3,470-2540000
       Deferred Long Term Liability 
0
0
0
0
0
646
0
954
630
357
104
0
0
00104357630954064600000
> Total Stockholder Equity
11,848
10,991
11,875
20,833
36,726
45,922
49,922
54,171
57,912
86,628
150,275
312,674
594,521
594,521312,674150,27586,62857,91254,17149,92245,92236,72620,83311,87510,99111,848
   Common Stock
4,800
4,800
4,800
4,800
5,900
5,900
5,900
23,600
23,600
36,100
41,000
42,970
100,000
100,00042,97041,00036,10023,60023,6005,9005,9005,9004,8004,8004,8004,800
   Retained Earnings 
5,699
4,454
6,031
11,575
16,183
22,780
26,902
25,618
27,774
32,228
93,161
207,634
463,841
463,841207,63493,16132,22827,77425,61826,90222,78016,18311,5756,0314,4545,699
   Capital Surplus 0000000000000
   Treasury Stock000000-94000000
   Other Stockholders Equity 
0
0
0
0
2,516
5,115
5,087
4,952
8,161
18,230
9,183
9,192
8,865
8,8659,1929,18318,2308,1614,9525,0875,1152,5160000



6.3. Balance Sheets

Currency in TRY. All numbers in thousands.




6.4. Cash Flows

Currency in TRY. All numbers in thousands.




6.5. Income Statements

Currency in TRY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in TRY. All numbers in thousands.

Gross Profit (+$)
totalRevenue52,558
Cost of Revenue-40,946
Gross Profit11,61211,612
 
Operating Income (+$)
Gross Profit11,612
Operating Expense-67,490
Operating Income-14,932-55,877
 
Operating Expense (+$)
Research Development7,635
Selling General Administrative10,150
Selling And Marketing Expenses-
Operating Expense67,49017,785
 
Net Interest Income (+$)
Interest Income15,938
Interest Expense-15,472
Other Finance Cost-31,948
Net Interest Income-31,482
 
Pretax Income (+$)
Operating Income-14,932
Net Interest Income-31,482
Other Non-Operating Income Expenses-
Income Before Tax (EBT)262,488-14,932
EBIT - interestExpense = -15,472
249,437
264,909
Interest Expense15,472
Earnings Before Interest and Taxes (EBIT)-277,960
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax262,488
Tax Provision-13,112
Net Income From Continuing Ops249,376249,376
Net Income249,437
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-31,482
 

Technical Analysis of RTA Laboratuvarlari Biyolojik
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of RTA Laboratuvarlari Biyolojik. The general trend of RTA Laboratuvarlari Biyolojik is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine RTA Laboratuvarlari Biyolojik's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of RTA Laboratuvarlari Biyolojik.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 20.54 < 32.56.

The bearish price targets are: 16.11 > 13.96 > 13.57.

Tweet this
RTA Laboratuvarlari Biyolojik Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of RTA Laboratuvarlari Biyolojik. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

RTA Laboratuvarlari Biyolojik Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of RTA Laboratuvarlari Biyolojik. The current macd is -0.15134591.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the RTA Laboratuvarlari Biyolojik price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for RTA Laboratuvarlari Biyolojik. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the RTA Laboratuvarlari Biyolojik price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
RTA Laboratuvarlari Biyolojik Daily Moving Average Convergence/Divergence (MACD) ChartRTA Laboratuvarlari Biyolojik Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of RTA Laboratuvarlari Biyolojik. The current adx is 16.86.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy RTA Laboratuvarlari Biyolojik shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
RTA Laboratuvarlari Biyolojik Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of RTA Laboratuvarlari Biyolojik. The current sar is 18.89.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
RTA Laboratuvarlari Biyolojik Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of RTA Laboratuvarlari Biyolojik. The current rsi is 47.95. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
RTA Laboratuvarlari Biyolojik Daily Relative Strength Index (RSI) ChartRTA Laboratuvarlari Biyolojik Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of RTA Laboratuvarlari Biyolojik. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the RTA Laboratuvarlari Biyolojik price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
RTA Laboratuvarlari Biyolojik Daily Stochastic Oscillator ChartRTA Laboratuvarlari Biyolojik Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of RTA Laboratuvarlari Biyolojik. The current cci is -58.68494704.

RTA Laboratuvarlari Biyolojik Daily Commodity Channel Index (CCI) ChartRTA Laboratuvarlari Biyolojik Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of RTA Laboratuvarlari Biyolojik. The current cmo is -5.53923127.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
RTA Laboratuvarlari Biyolojik Daily Chande Momentum Oscillator (CMO) ChartRTA Laboratuvarlari Biyolojik Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of RTA Laboratuvarlari Biyolojik. The current willr is -67.36842105.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that RTA Laboratuvarlari Biyolojik is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
RTA Laboratuvarlari Biyolojik Daily Williams %R ChartRTA Laboratuvarlari Biyolojik Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of RTA Laboratuvarlari Biyolojik.

RTA Laboratuvarlari Biyolojik Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of RTA Laboratuvarlari Biyolojik. The current atr is 1.22537716.

RTA Laboratuvarlari Biyolojik Daily Average True Range (ATR) ChartRTA Laboratuvarlari Biyolojik Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of RTA Laboratuvarlari Biyolojik. The current obv is 641,091,862.

RTA Laboratuvarlari Biyolojik Daily On-Balance Volume (OBV) ChartRTA Laboratuvarlari Biyolojik Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of RTA Laboratuvarlari Biyolojik. The current mfi is 44.53.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
RTA Laboratuvarlari Biyolojik Daily Money Flow Index (MFI) ChartRTA Laboratuvarlari Biyolojik Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for RTA Laboratuvarlari Biyolojik.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

RTA Laboratuvarlari Biyolojik Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of RTA Laboratuvarlari Biyolojik based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.952
Ma 20Greater thanMa 5017.601
Ma 50Greater thanMa 10018.691
Ma 100Greater thanMa 20015.806
OpenGreater thanClose17.360
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of RTA Laboratuvarlari Biyolojik with someone you think should read this too:
  • Are you bullish or bearish on RTA Laboratuvarlari Biyolojik? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about RTA Laboratuvarlari Biyolojik? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about RTA Laboratuvarlari Biyolojik

I send you an email if I find something interesting about RTA Laboratuvarlari Biyolojik.


Comments

How you think about this?

Leave a comment

Stay informed about RTA Laboratuvarlari Biyolojik.

Receive notifications about RTA Laboratuvarlari Biyolojik in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.